Prelude Therapeutics (PRLD) EPS (Basic) (2019 - 2026)
Prelude Therapeutics' (PRLD) quarterly EPS (Basic) came in at -$0.13 in Q1 2026, up 69.05% year-on-year from -$0.08 in Q1 2025, and up 35.0% quarter-over-quarter from -$0.2 in Q4 2025.
Prelude Therapeutics (PRLD) EPS (Basic) (2019 - 2026) Analysis & Trends
Prelude Therapeutics has disclosed EPS (Basic) across 8 years of filings, most recently posting -$0.13 for Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$0.13, up 69.05% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.0 (up 40.83% YoY), and the FY2025 annual result was -$1.29, up 23.21% from the prior year.
- EPS (Basic) came in at -$0.13 for Q1 2026 at Prelude Therapeutics, up from -$0.2 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.13 in Q1 2026 to a low of -$0.63 in Q1 2022.
- The 5-year median for EPS (Basic) is -$0.45 (2023), against an average of -$0.45.
- Across the five-year window, EPS (Basic) slumped 34.04% in 2022 and surged 69.05% in 2026, its largest moves.
- Prelude Therapeutics' EPS (Basic) stood at -$0.6 in 2022, then climbed by 21.67% to -$0.47 in 2023, then advanced by 19.15% to -$0.38 in 2024, then surged by 47.37% to -$0.2 in 2025, then surged by 35.0% to -$0.13 in 2026.
- The last three EPS (Basic) figures came in at -$0.13 (Q1 2026), -$0.2 (Q4 2025), and -$0.26 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 0.00 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 0.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -0.06 |
| 10 | Prelude Therapeutics | 314.40 Mn | 169.80 Mn | - | -0.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.13 |
| Dec 31, 2025 | -0.20 |
| Sep 30, 2025 | -0.26 |
| Jun 30, 2025 | -0.41 |
| Mar 31, 2025 | -0.42 |
| Dec 31, 2024 | -0.38 |
| Sep 30, 2024 | -0.43 |
| Jun 30, 2024 | -0.46 |
| Mar 31, 2024 | -0.42 |
| Dec 31, 2023 | -0.47 |
| Sep 30, 2023 | -0.45 |
| Jun 30, 2023 | -0.54 |
| Mar 31, 2023 | -0.58 |
| Dec 31, 2022 | -0.60 |
| Sep 30, 2022 | -0.63 |
| Jun 30, 2022 | -0.58 |
| Mar 31, 2022 | -0.63 |
| Dec 31, 2021 | -0.71 |
| Sep 30, 2021 | -0.66 |
| Jun 30, 2021 | -0.58 |